The Archive · 4 posts
Explore innovative healthcare solutions with Uniphar PLC (UPR)! 🌟 Elevating the supply chain across the medical industry with passion and precision. 💡
Uniphar delivered 11% adjusted EPS growth in the first half, although a facility delay will require another €20 million of spending.
July 28, 2026
Showing 3 of 4 posts
Record organic growth drives Uniphar's strongest year since IPO, with Adjusted EPS jumping 21% and a clear path to its €200m EBITDA target.
JoshuaFebruary 24, 2026
Uniphar's 2025 beats expectations with 21% adjusted EPS growth and 1.5x leverage, setting a strong stage for 2026.
JoshuaJanuary 27, 2026
Uniphar's 2025 interims show strong 21% adjusted EPS growth, divisional progress, and strategic momentum. Read the full analysis and key takeaways here.
JoshuaSeptember 2, 2025
September 2, 2025